Press release
New drugs for Rabies excite: Key takeaway from Assessment Analysis
Rabies
Request a sample report @ https://www.htfmarketreport.com/sample-report/2361053-rabies-pipeline-review
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rabies - Pipeline Review, H2 2019, provides an overview of the Rabies (Infectious Disease) pipeline landscape.
Rabies is a deadly virus spread to people from the saliva of infected animals. The rabies virus is usually transmitted through a bite. Symptoms include loss of feeling in an area of the body, loss of muscle function, swallowing difficult, excitability, fever and convulsions. The predisposing factors include exposure to wildlife and exposure to other pets that may not be vaccinated.
Companies Mentioned in the Report
Abhelix LLC, Beijing Minhai Biotechnology Co Ltd, Cadila Healthcare Ltd, Changchun Bcht Biotechnology Co Ltd, Chengdu Rongsheng Pharmaceutical Co Ltd, Chongqing Zhifei Biological Products Co Ltd, CPL Biologicals Pvt Ltd, Curevac AG, GlaxoSmithKline Plc, Humabs BioMed SA, Indian Immunologicals Ltd, Mid-Atlantic BioTherapeutics, Inc., Molecular Targeting Technologies Inc, NanoViricides Inc, Sanofi, Sanofi Pasteur SA, Shandong Yidu Biotechnology Co Ltd, Synermore Biologics Co Ltd, Trellis Bioscience Inc, Yisheng Biopharma Co Ltd
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Rabies - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Rabies (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/2361053-rabies-pipeline-review
The Rabies (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rabies and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 6, 3, 4, 3, 11 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 6 and 1 molecules, respectively.
Rabies (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Rabies (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Rabies (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Rabies (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Rabies (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Rabies (Infectious Disease)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Rabies (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Rabies (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/2361053-rabies-pipeline-review
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Rabies - Overview
Rabies - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
....Continued
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=2361053
Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com
Connect with us at LinkedIn | Facebook | Twitter
About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New drugs for Rabies excite: Key takeaway from Assessment Analysis here
News-ID: 1889269 • Views: …
More Releases from HTF Market Intelligence Consulting Pvt. Ltd.
Insurance Audit Market May See a Big Move | Major Giants Deloitte, KPMG, PwC
HTF MI just released the Global Insurance Audit Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2033. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Giants in Insurance Audit Market are:
Deloitte (US), KPMG (Netherlands), PwC…
Smoke Oil Market Is Booming So Rapidly | Amazing Oil, SmokeMaster, AromaTech
HTF MI just released the Global Smoke Oil Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2033. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Giants in Smoke Oil Market are:
Nordic Oil (Denmark), Blue Smoke…
Tire Repair Patch Market May See Big Move | Bridgestone, Michelin, Goodyear
HTF MI just released the Global Tire Repair Patch Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2033. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Giants in Tire Repair Patch Market are:
Bridgestone (Japan), Michelin…
Biodegradable Food Wrappers Market is Going To Boom | Paper Wrap, NatureWorks, R …
HTF MI just released the Global Biodegradable Food Wrappers Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2033. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Giants in Biodegradable Food Wrappers Market are:
BASF (Germany), TIPA…
More Releases for Rabies
Rabies Antiserum Market Growing with Global Rabies Prevention Efforts and Emerge …
Rabies Antiserum Market is estimated to be valued at USD 1.32 Bn in 2025 and is expected to reach USD 1.66 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 3.3% from 2025 to 2032.
The qualitative latest Research report (2025-2032) on the Rabies Antiserum Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size,…
Key Trends Influencing the Growth of the Rabies Diagnostics Market in 2025: Prod …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Rabies Diagnostics Market Through 2025?
The market size for rabies diagnostics has seen significant growth in recent years. The market, which was worth $1.68 billion in 2024, is anticipated to expand to $1.78 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.6%. Factors such…
Top Factor Driving Rabies Diagnostics Market Growth in 2025: Increasing Prevalen …
What market dynamics are playing a key role in accelerating the growth of the rabies diagnostics market?
The market for rabies diagnostics is likely to be propelled by the escalating incidence of rabies. Rabies, a viral disease that can be prevented, is typically transmitted through a bite from an infected animal. It targets the central nervous system of mammals, leading to brain damage and eventual death. Various diagnostic tests and methods…
Rabies Diagnostics Market is Driven by High Prevalence of Rabies in the World
Global Rabies Diagnostics Market: Overview
Neglected tropical diseases have usually plagued densely populated areas with low resource availability across the globe. Rabies is one such neglected tropical disease that has always troubled animal and human population, especially in the African and Asian countries. The global rabies diagnostics market is likely to gather momentum from such high prevalence of rabies in these parts of the world.
Read Report Overview - https://www.transparencymarketresearch.com/rabies-diagnostics-market.html
Global Rabies Diagnostics…
Rabies Treatment Market 2017 | Sanofi, GlaxoSmithKline, Cadila Healthcare
Global Rabies Treatment Market: Snapshot
Earlier, widespread culling of animals was embarked upon to stamp out rabies – a fatal disease caused by rabies virus transmitted from animals to humans. Domestic dogs are mainly the carriers of the virus and over 95.0% of human deaths result from dog-mediated rabies, states WHO. It also finds that Asia and Africa account for almost 95.0% of the tens of thousands of rabies deaths occurring…
Rabies Vaccine Market Report 2018: Segmentation by Product (Vero Cell Rabies Vac …
Global Rabies Vaccine market research report provides company profile for Novartis Vaccines and Diagnostics Ltd., Cadila Pharmaceuticals Ltd., GlaxoSmithKline Biologicals, Merck & Co Inc., Wyeth pharmaceuticals, Berna Biotech Ltd. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year…
